Keyphrases
Deferiprone
100%
Agranulocytosis
100%
Neutrophils
30%
Neutropenia
30%
Rechallenge
30%
Dose Effect
20%
Reactive Species
20%
Immune Response
10%
Clinical Characteristics
10%
Iron Chelator
10%
First Episode
10%
Serious Adverse Effects
10%
Lag Period
10%
Hypochlorous Acid
10%
Orally Active
10%
Reactive Metabolites
10%
Active Iron
10%
Re-exposure
10%
Patient Support
10%
Re-induction
10%
Immune Defense
10%
Bone Marrow Aspiration
10%
Severe Neutropenia
10%
Myeloid Precursors
10%
Pharmacology, Toxicology and Pharmaceutical Science
Deferiprone
100%
Agranulocytosis
100%
Neutropenia
40%
Adverse Event
10%
Oxidizing Agent
10%
Iron Chelating Agent
10%
Hypochlorous Acid
10%